baber/WOPTO huggingface dataset:
Patent NZ-314629-A (NZ)
Title: Use trans-splicing ribozymes to prepare medicaments for gene therapies
Inventor: HASELOFF JAMES
IPC: C07K7/06
Filed: 1992-01-15
Abstract: The specification describes the use of trans-splicing ribozymes for delivering desired genetic sequences to a cell.  Envisaged,for example, is the ability to diffuse the effects of diphtheria toxin A
Patent NZ-331741-A (NZ)
Title: use of a quinazolin-4-one derivative having an (S)-configuration to treat dyskinesia associated with dopamine agonist therapy
Inventor: CHENARD BERTRAND LEO
IPC: A61K31/4525
Filed: 1998-09-04
Abstract: Certain named quinazoline derivatives are used in a manufacture of a medicament to treat dyskinesia associated with dopamine agonist therapy in a mammal. The quinazoline derivatives have the formula I wherein: A is an optionally substituted fused 5 or 6 membered heteroaromatic ring of formula II or III with the ring positions A, B, D and E being independently carbon or nitrogen and the ring positions F, G and J being independently carbon, nitrogen, oxygen or sulphur; the ring positions V, X, Y and Z are all carbon or one of them is nitrogen and the others are carbon; R6 is a phenyl of formula IV or an optionally substituted fused 5 or 6 membered heteroaromatic ring of formula V or VI with the ring positions K, L and M being independently carbon or nitrogen and the ring positions P, Q and T being independently carbon, nitrogen, oxygen or sulphur and the rest of the variables are defined in the specification limited by the provisos listed in the specification.
Patent NZ-333544-A (NZ)
Title: System and method for adaptive interference cancelling
Inventor: MARASH JOSEPH
IPC: G01S7/288
Filed: 1997-06-23
Abstract: An adaptive system and method for reducing interference in a signal received from an array of sensors. Adaptive filters are used to generate canceling signals that closely approximate the interference present in the received signal. The adaptive filter weights are converted into the frequency domain where the frequency representation values in a selected frequency range are truncated to avoid signal leakage involving narrow band signals. Decolorizing filters are used to produce the canceling signals having a flat frequency spectrum. Normalized power difference is used to limit the operation of the adaptive filters to the case where there is some directional interference to be eliminated.
Patent NZ-334586-A (NZ)
Title: Controlling depth of anaesthesia, evaluating EEG traces of patient subjected to auditory stimulus
Inventor: MANTZARIDIS HARALAMBOS
IPC: A61B5/11
Filed: 1997-09-10
Abstract: An anaesthesia control system and a method of calculating an index representative of the depth of anaesthesia. The method comprises subjecting a patient to a repetitive audio stimulus and monitoring auditory evoked potentials (AEP) produced by the patient and then recording these auditory evoked potentials using EEG recording means and providing a signal corresponding to the measure of the curvature of the monitored AEP signal and using this signal as an index indicative of anaesthetic depth. The raw AEP signal is divided into a series of sweeps and each sweep is synchronised with the repetitive audio stimulus and sweeps are recorded in sequence to produce a time averaged sweep from which the anaesthetic index is calculated. The anaesthetic index is constantly updated by repeatedly conducting a successive series of sweeps. The system and index signal can be used as part of an anaesthesia control system for regulating the supply of anaesthetic to the patient to maintain the anaesthetic index at a predetermined level.
Patent NZ-502687-A (NZ)
Title: Electrical flush box mounting device
Inventor: MURPHY PAUL A
IPC: H02G3/08
Filed: 2000-02-02
Abstract: A flush mounting box (2) having mounting holes, allowing an electrical plate to be installed in an aperture formed in wall board comprises a box means having side portions (4,6), an open back face portion (11), an open front face portion, a top portion (8) and a bottom portion (10).  Teeth means (15,16) extend from top and bottom portions (8,10) at the front and back face thereof.  Teeth means (15,16) are pressed into the wallboard when in use.  Flange means (12,13) extend from top and bottom portions (8,10) to guide teeth means (15,16) to hold the mounting box (2) on the edges of the wall aperture and whereby the box may be mounted in a wall space to be covered by a wall facing material i.e. gypsum board. The flange means (12,13) bears against the back of the wall facing material.  The flush mounting box is resiliently flexible so that it may be deformed to pass through the aperture in the wallboard.  .
Patent NZ-506802-A (NZ)
Title: 6-Benzofuran-2-yl substituted 2H-pyran-2-one derivatives
Inventor: TAKEUCHI TOMIO
IPC: A61P7/00
Filed: 1999-03-12
Abstract: A benzofuryl-a-pyrone derivative or a salt thereof has the formula (I) wherein: R1 is hydrogen or alkyl; R2 is hydrogen, -CO-R5, or -SO2R6; R3 is hydrogen, alkyl, alkenyl, alkynyl,  cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl or aryloxy; R4 is a substituent at the C-4 position, C-5 position, C-6 position or C-7 position of the benzofuran ring and is hydrogen, nitro, cyano, halogen, heterocycle, alkenyl, alkynyl, aryl, A=CH(CH2)m-, A=CH(CH2)mO-, A-SO2-(CH2)m-, -OR7, -O-CO-R8, -NR9R10, -CO-R13 or -CO-NR14R15, an optionally saturated optionally substituted alkoxy; or an optionally substituted alkyl; R5 is hydrogen, optionally substituted alkyl, cycloalkyl, aryl or a heterocycle; R6 is an optionally halogen-substituted alkyl or aryl and A, m, R7-R10 and R13-R15 are as defined in the specification and the numbers in italics is the positions on the benzofuran ring. The above compounds are useful as lipid metabolism enhancers, arteriosclerosis prophylactic agents, arteriosclerosis treatment agents, triglyceride biosynthesis inhibitors, blood triglyceride lowering agents or blood HDL elevating agents.
Patent NZ-510206-A (NZ)
Title: Method of enhancing humoral or cellular responses initiated by DNA vaccination
Inventor: CHARO JEHAD
IPC: A61P37/04
Filed: 1999-08-25
Abstract: A vaccine composition comprises a nucleotide sequence that encodes for an antigenic peptide associated with a disease state and which is within an appropriate vector and a compound. The compound will enhance both humoral and cellular immune responses in a mammal, which are initiated by the antigenic peptide. Preferably the compound is 4-(2-formyl-hydroxyphenoxymethyl) benzoic acid. Also described are the uses of the compound in a medicament for enhancing humoral and cellular responses initiated by an antigenic peptide associated with a disease sate in a mammal. The peptide being expressed as a result of the administration of a nucleotide sequence encoding for the peptide.
Patent NZ-512080-A (NZ)
Title: Photoinitiators and oxygen scavenging compositions
Inventor: KATSUMOTO KIYOSHI
IPC: C07C45/46
Filed: 1998-04-16
Abstract: The photoinitiators provided are selected from optionally substituted tribenzoyl triphenylbenzenes and optionally substituted benzyolyated styrene oligomers containing from 2 to 12 repeating styrenic groups.  The substituents are selected from alkyl, aryl, alkoxy, phenoxy or alicyclic groups containing 1 to 24 carbon atoms or halides.
Patent NZ-513674-A (NZ)
Title: Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
Inventor: DUCOUX JEAN PHILIPPE
IPC: C07D265/30
Filed: 2000-03-21
Abstract: Compounds of formula (1), processes for the preparation thereof, and the use for treating pathologies that involve the substance P (the endogenous ligand of the NK1 receptor) and/or the tachykinin receptor subtype, human NK1 receptors.
Patent NZ-515942-A (NZ)
Title: Method for making a surfboard
Inventor: CHEN YU-TSAI
IPC: B63B35/79
Filed: 2001-12-05
Abstract: A method of making a surfboard comprising the steps of: a) forming a small panel for making the surfboard from one of ethylene vinyl acetate (EVA) and polyethylene (PE) foamable material; b) hot pressing the panel in a heating mold by placing the panel in a mold cavity having a surfboard shape and bounded by upper and lower mold portions and heating the panel to a temperature between 150°C-170°C for between 30 to 40 minutes to partially foam the foamable material of the panel. c) removing the partially foamed panel from the mold and allowing the panel to continue foaming and expanding until reaching a volume of between 6-10 times greater than an initial volume of the panel. d) placing the panel in a baking device and baking the panel at a temperature of between 150°C-200°C for between 10 and 30 minutes to complete the foaming of the panel. e) removing the panel from the baking device and placing the panel in a cooling mold at a temperature of between 30°C-60°C for between 10 and 30 minutes to cool and harden the panel into complete surfboard; and f) removing the complete surfboard from the cooling mold.
Patent NZ-518452-A (NZ)
Title: Oxime O-ether compounds and fungicides for agricultural and horticultural use
Inventor: SANO HIROSHI
IPC: A01N43/40
Filed: 2000-11-02
Abstract: The application discloses oxime O-ether compounds represented by the general formula I (see below) wherein; R1 represents C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkoxy, C1-6 alkylthio, amino, mono- or di- (C1-6 alkyl) amino, C1-6 acyloxy, C1-6 alkoxy C1-6 alkyl, C1-6 haloalkyl, hydroxy or Halogen atom; m represents an integer of 1-4 and when m is 2 or more integers each of R1 may be the same or different form one another; R2 represents a hydrogen atom, C1-6 alkyl or C3-6 cycloalkyl; R3 and R4 are the same or different from one to another, and each independently represents a hydrogen atom or C1-6 alkyl; R5 represents a hydrogen atom, C1-6 alkyl, C3-6 cycloalkyl, C1-6 haloalkyl, C1-6 alkoxy C1-6 alkyl, C1-6 alkoxy C1-6 alkoxy C1-6 alkyl, C7-10 aralkyl, C7-10 aralkyloxy C1-6 alkyl, C1-6 alkylcarbonyl, C1-6 alkylsulfonyl or C1-6 haloalkylsulfonyl; R6 represents C1-6 alkyl, C3-6 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 alkoxy C1-6 alkoxy, C1-6 alkylcarbonyloxy, C1-6 alkoxy C1-6 alkyl, C1-6 haloalkyl, cyano, nitro, amino, mono- or di-(C1-6 alkyl) amino, C1-6 alkylcarbonylamino, C1-6 alkythio, hydroxy or a halogen atom; n represents an integer of 1 to 4 and when n is 2 or more integers, each of R6 may be the same or different from one to another. The oxime ether compounds can be used singly or in conjunction with other oxime ether compounds as fungicides for agricultural and horticultural use.
Patent NZ-520247-A (NZ)
Title: Razor cartridge and corresponding method of assembly
Inventor: ZUCKER SHLOMO
IPC: B26B21/20
Filed: 2001-02-16
Abstract: A razor cartridge employs a number of planar blades, each having an uninterrupted upper surface and a width measured across its upper surface perpendicular to its length of no more than about 4 mm. The blades are retained between abutment features provided by spaced-apart ribs of a base and opposing abutment surfaces of a cover. Also provided is method for assembling such cartridges by temporarily inserting locating elements through apertures formed either in the base or in the cover
Patent NZ-530023-A (NZ)
Title: HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
Inventor: CANON-KOCH STACIE S
IPC: C07K5/04
Filed: 2002-06-11
Abstract: Disclosed are compounds of formula I, wherein: R1 is optionally substituted phenyl, R2 is optionally substituted alkenyl or alkynyl, R2' is H, X is phenyl, Z is S, SO or SO2, R3, R4, R5, R8 and R8' are H, and R6 and R7 are methyl. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by HIV infection.
Patent NZ-532371-A (NZ)
Title: Data transmission in a packet-oriented communication network
Inventor: SCHRODI KARL
IPC: H04L12/54
Filed: 2002-09-20
Abstract: A method for transmitting traffic streams in a connectionless packet-oriented communication network that comprises a plurality of transmission nodes, which are connected together in such a way that a plurality of routes exist between the transmission nodes, whereby at least some of the transmission nodes are configured as ingress transmission nodes and/or egress transmission nodes of the communication network, comprises: subdividing the traffic streams into least two traffic classes - at least one without priority and at least one with priority; limiting the priority traffic streams via an admission control element, the admission control element functioning at the respective ingress node and the egress node for every traffic stream; sending the traffic streams from the ingress nodes to the egress nodes; for at least one of the transmission nodes receiving at least some of the traffic streams sent, more than one residual route extending from it to at least one of the egress nodes is identified, and distributing the traffic streams sent to this egress transmission node to at least two of the identified residual traffic routes.
Patent NZ-538515-A (NZ)
Title: Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
Inventor: ALLEN DAVID GEORGE
IPC: C07D221/00
Filed: 2003-09-12
Abstract: Pyrazolo[3,4-b]pyridine compounds of formula (I) or salts thereof are disclosed, wherein: R1 is C1-3alkyl, C1-2fluoroalkyl, -CH2CH2OH ; R2 is a hydrogen atom, methyl or C1fluoroalkyl; R3 is substituted C3-8cycloalkyl or an optionally substituted heterocyclic group of sub-formula (aa), (bb) or (cc); in which n1 and n2 independently are 1 or 2; and in which Y is O, S, SO2, or NR10; and wherein X is NR4R5 or OR5a. These compounds are phosphodiesterase (PDE) inhibitors, in particular PDE4 inhibitors. Also disclosed is the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment and/or prophylaxis of an inflammatory and/or allergic disease in a mammal such as a human, for example chronic obstructive pulmonary disease (COPD), asthma, or allergic rhinitis.
Patent NZ-538743-A (NZ)
Title: Aerosol formulation for inhalation containing an anticholinergic agent
Inventor: SCHMIDT FRIEDRICH
IPC: A61K31/33
Filed: 2003-07-25
Abstract: Disclosed herein is an aqueous pharmaceutical preparation for inhalation that comprises as sole active substance a compound of formula 1, in which X - represents an anion and its use for preparing a medicament for treating respiratory complaints. Also disclosed herein is a kit that comprises said pharmaceutical preparation and an inhaler suitable for nebulising this pharmaceutical preparation.
Patent NZ-541573-A (NZ)
Title: Thermoplastic polycarbonate compositions with improved mechanical properties, articles made therefrom and method of manufacture
Inventor: VOLKERS ANDRIES ADRIAAN
IPC: C08L69/00
Filed: 2005-07-29
Abstract: Disclosed herein is a thermoplastic composition having improved mechanical properties, consisting essentially of: a polycarbonate resin; a mineral filler; an acid or acid salt, wherein said acid comprises sulphuric acid or a phosphorus containing oxy-acid and wherein said acid salt is selected from the group consisting of: sulphites, mono zinc phosphates, mono calcium phosphates and mono natrium phosphate; optionally, an aromatic vinyl copolymer; and optionally, an impact modifier; wherein the acid or acid salt is present in the composition in a weight ratio of acid to filler of at least 0.0035:1.
Patent NZ-543526-A (NZ)
Title: Barrier system to assist in creating a culvert over a waterway, the barrier made from a honeycombed material
Inventor: HARRIS ROSS HUGH
Filed: 2005-11-10
Abstract: A barrier for a barrier system is disclosed. The barrier includes a retainer (2) structured to receive and retain a post or posts (4) and a surface bounded by a top edge and a side edge wherein the side edge is inclined with respect to the top edge. The surface of the retainer (2) has a honeycomb structure. The posts (4) may be retained by brackets (3) on the surface of the retainer (2) or by passing through a passage in the retainer. In use, two such barriers retain soil or similar to create a culvert (12) over a stream or drainage ditch (11).
Patent NZ-551419-A (NZ)
Title: Housing for measuring device such as electricity, gas or water meter, with flange to direct moisture to front
Inventor: WEGGERY JAMES CHARLES
IPC: H05K5/00
Filed: 2006-11-17
Abstract: A housing for a measuring device such as an electricity, gas or water meter box is disclosed for mounting to a building wall (not shown). The housing has a roof, two sides and a front which, when installed, faces away from the building. A first flange 13 is provided for securing to the building and a second flange 14 directs moisture to the front of the housing.
Patent NZ-551785-A (NZ)
Title: Sign support including legs which nest together when sign is collapsed
Inventor: HOWLETT GORDON FRANCIS
Filed: 2006-12-01
Abstract: A sign support, for a temporary road sign, includes a sign holding means and a plurality of leg holding means positioned about the sign holding means. Each leg holding means is adapted to pivotally receive a respective leg which is able to pivot between a first position providing a support for a sign and a second position in which, with the sign collapsed, the legs are able to substantially nest together in order to minimise the height of the collapsed sign. Each leg includes an upper portion adapted to be accommodated within a respective leg holding means and a lower portion extending outwardly to an end portion. The upper portion of each leg is able to slide substantially vertically, in use, within a respective leg holding means, so as to facilitate use of the sign support on uneven ground.
Patent NZ-553842-A (NZ)
Title: Coating composition based on thiol-NCO curing
Inventor: STAPPERS FRANCISCUS HUBERTUS MARIA
IPC: C08G18/38
Filed: 2005-09-16
Abstract: Disclosed is a coating composition comprising one or more polythiols and one or more polyisocyanates and a latent base catalyst which is activatable by moisture, wherein the equivalence ratio NCO : SH is between 1:2 and 2:1.
Patent NZ-561187-A (NZ)
Title: Electrical wall socket with inbuilt overtemperature and overcurrent switch
Inventor: GILLS JOHN
Filed: 2007-09-04
Abstract: A electrical wall socket fitting includes phase, neutral and earth terminals and related pin sockets, and either a thermal sensor sensitive to temperature changes due to current flow through the outlet or, alternatively, a current sensor for current flowing through the outlet, an internal switch to interrupt current flow through the outlet, and a control circuit connected to the internal switch and the thermal sensor or the current sensor, to operate the internal switch to interrupt power flow through the outlet in the event of the temperature exceeding a predetermined threshold temperature or the current exceeding a predetermined threshold current. The control circuit also detects the voltage difference between the phase and at least one of the earth and neutral terminals and operates the internal switch to interrupt the power flow through the outlet if the voltage difference exceeds a predetermined voltage surge threshold or is less than a predetermined voltage sag threshold.
Patent NZ-561300-A (NZ)
Title: Time domain reflectomertry system and method of use
Inventor: WOODHEAD IAN MAXWELL
IPC: G01R27/00
Filed: 2007-09-07
Abstract: A non-invasive Time Domain Reflectometry (TDR) transmission line system (1) and method for measuring one or more parameters of an electromagnetic Radio Frequency (RF) pulse transmitted, and reflected, along a transmission line are disclosed. The parameters include at least one of; amplitude, propagation velocity and/or propagation time between defined predetermined instances. The system (1) includes a transmission line (6) including three or more elongated transmission elements (2, 3, 4, 5), respectively having two distal ends (2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b). Each element (2, 3, 4, 5) is capable of being selectively activated to transmit the RF pulse. A mounting assembly (7) is provided for mounting the transmission elements (2, 3, 4, 5) at the first end (2a, 3a, 4a, 5a) to form a spatially-separated transmission element array (6) with the other 'second' distal end (2b, 3b, 4b, 5b) of each transmission element (2,3, 4, 5) being spaced from the mounting assembly (7). An RF source is configured to transmit the RF pulse along the transmission line (6) to activate a selected pair of the transmission elements (2, 3, 4, 5) to generate an electric field between the transmission elements (2, 3, 4, 5) of the pair. The transmission elements (2, 3, 4, 5) are capable of selective activation in at least two distinct pairs having distinct geometric configurations relative to each other to generate at least two distinct electric field potentials without physical displacement of the transmission line (6).
Patent NZ-562292-A (NZ)
Title: Variant forms of urate oxidase and use thereof
Inventor: HARTMAN JACOB
IPC: A61K47/48
Filed: 2006-04-11
Abstract: Disclosed is an isolated truncated mammalian uricase comprising a mammalian uricase amino acid sequence truncated at the amino terminus or the carboxy terminus or both the amino and carboxy termini by 1 - 13 amino acids and further comprising an amino acid substitution at position 46 with respect to the native pig uricase.
Patent NZ-565733-A (NZ)
Title: Use of a plant apyrase enzyme in the modification of endophyte infection
Inventor: ROBERTS NICHOLAS JOHN
IPC: C12N15/55
Filed: 2006-08-14
Abstract: Disclosed is a substantially purified, recombinant, synthetic or isolated nucleic acid encoding an apyrase polypeptide, or complementary or antisense to a nucleic acid sequence encoding an apyrase polypeptide, wherein said nucleic acid includes a nucleotide sequence selected from the group consisting of (a) the sequence shown in SEQ ID NO: 1; (b) the complement of the sequence recited in (a); (c) a sequence antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c) having at least approximately 80% identity to the relevant part of the sequence recited in (a), (b) or (c) and having a size of at least 30 nucleotides; and (e) interfering RNA (RNAi) derived from the sequences recited in (a) and (b). Further disclosed is a substantially purified, recombinant, synthetic or isolated apyrase polypeptide from a Lolium species, wherein said polypeptide includes an amino acid sequence selected from the amino acid sequence shown in SEQ ID NO: 2, and functionally active fragments and variants thereof having at least approximately 80% identity to the relevant part of SEQ ID NO: 2 and having a size of at least 20 amino acids.